ENTRY       D04665                      Drug
NAME        Lanoteplase (USAN/INN);
            Lanoteplase (genetical recombination) (JAN)
SEQUENCE    GARSYQVIDT RATCYEDQGI SYRGTWSTAE SGAECTNWQS SALAQKPYSG RRPDAIRLGL
            GNHNYCRNPD RDSKPWCYVF KAGKYSSEFC STPACSEGNS DCYFGNGSAY RGTHSLTESG
            ASCLPWNSMI LIGKVYTAQN PSAQALGLGK HNYCRNPDGD AKPWCHMLKN RRLTWEYCDV
            PSCSTCGLRQ YSQPQFRIKG GLFADIASHP WQAAIFAKHR RSPGERFLCG GILISSCWIL
            SAAHCFQERF PPHHLTVILG RTYRVVPGEE EQKFEVEKYI VHKEFDDDTY DNDIALLQLK
            SDSSRCAQES SVVRTVCLPP ADLQLPDWTE CELSGYGKHE ALSPFYSERL KEAHVRLYPS
            SRCTSQHLLN RTVTDNMLCA GDTRSGGPQA NLHDACQGDS GGPLVCLNDG RMTLVGIISW
            GLGCGQKDVP GVYTKVTNYL DWIRDNMRP
            (Disulfide bridge: 14-95, 35-77, 66-90, 102-183, 123-165, 154-178, 186-317, 229-245, 237-306, 331-406, 363-379, 396-424; Glycosylation site: 106, 370)
  TYPE      Peptide
CLASS       Blood modifier agent
             DG01950  Antithrombotic agent
              DG01707  Fibrinolytic
               DG01664  Tissue plasminogen activator (t-PA)
EFFICACY    Thrombolytic, Tissue plasminogen activator (t-PA)
COMMENT     recombinant tissue plasminogen activator (rt-PA) [HSA:5327] [KO:K01343] [EC:3.4.21.68]
INTERACTION  
BRITE       Drug groups [BR:br08330]
             Blood modifier agent
              DG01950  Antithrombotic agent
               DG01707  Fibrinolytic
                DG01664  Tissue plasminogen activator (t-PA)
                 D04665  Lanoteplase
DBLINKS     CAS: 171870-23-8
            PubChem: 17398133
///
